NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/10/2026
Back to search
Official data from USPTO
SUMMIT THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
SUMMIT THERAPEUTICS
ST13
US500000098977458Class
42, 44
Filing
98977458
Registration
8171341
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
06/19/2026
Classification
Registered
Trademark type
Word
Nice classes
42, 44
Filing date
04/08/2024
Registration date
03/10/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2026
Last transaction
06/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/06/2022
First use in commerce
12/06/2022
Drawing code
4
Owner type
03
Owner location
Menlo Park, CA, US
Examiner
DETMER, CAROLYN ROSE
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SUMMIT THERAPEUTICS SUB INC.
Representatives
Andrea M. Porterfield Polsinelli PC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Drug discovery services for the identification and analysis of therapeutics for use in oncology and immuno-oncology; Research and development services in the field of therapeutics for the treatment of cancer; Research and development services in the fields of oncology and immuno-oncology; Providing medical and scientific research information in the field of biopharmaceuticals; Providing medical and scientific research information in the field of cancer
Class 44
Healthcare services, namely, providing patient treatment services in the fields of oncology and immuno-oncology; Provision of medical services in the field of oncology and immuno-oncology for the treatment of patients; Advice relating to oncology and immuno-oncology; Providing medical care services in the field of oncology and immuno-oncology; Providing medical information in the field of cancer; Medical counseling in the field of oncology and immuno-oncology; Clinical medical consulting in the field of oncology and immuno-oncology
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/13/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/13/2026
DOCK
ASSIGNED TO EXAMINER
02/12/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/26/2026
DPCC
DIVISIONAL PROCESSING COMPLETE
01/26/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/16/2026
IUAF
USE AMENDMENT FILED
05/08/2025
DRRR
DIVISIONAL REQUEST RECEIVED
05/07/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
05/07/2025
EISU
TEAS STATEMENT OF USE RECEIVED
05/07/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2025
PUBO
PUBLISHED FOR OPPOSITION
01/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/23/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
10/23/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/23/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
10/23/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/23/2024
DOCK
ASSIGNED TO EXAMINER
10/22/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/16/2024
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
04/12/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/12/2024
NWAP
NEW APPLICATION ENTERED
04/08/2024
Continuous trademark protection
Get notified about every new filing that threatens SUMMIT THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.